Vijaya Diagnostic Centre Q2 Profit Soars 37% YoY

Consolidated revenue stood at Rs 255.39 crore; Net profit reached Rs 59.47 crore.
Reader Takeaway: Strong operational growth driven by diagnostic services demand, supported by the integration of Medinova Diagnostic.

What just happened

Vijaya Diagnostic Centre Ltd has released its unaudited financial results for the second quarter and half-year ended September 30, 2026. The company posted a significant increase in both revenue and profit on a year-over-year basis. Additionally, the board has approved the appointment of Mr. Rahul Jain as the Company Secretary and Compliance Officer, effective November 3, 2026.

Why this matters

The financial results highlight a strong growth trajectory for the diagnostic chain. Consolidated net profit rose to Rs 59.47 crore compared to Rs 43.28 crore in the same period last year. Revenue growth of 26.7% indicates healthy demand for its diagnostic services. The appointment of a new KMP marks a routine but essential governance update to ensure regulatory compliance.

Financial Highlights

On a standalone basis, the company reported revenue of Rs 242.00 crore, reflecting a 27.4% growth compared to the previous year. Standalone net profit grew by 34.8% to Rs 57.92 crore. The financial statements account for the amalgamation of Medinova Diagnostic Services Limited through the restatement of prior-period data as per accounting standards.

What to track next

Investors should continue to monitor the integration of the Medinova business and the company's ability to maintain these margins in future quarters. The firm also disclosed the issuance of 100,987 equity shares following the exercise of employee stock options, a factor to consider for share dilution assessments.